Roche has a long history of being relatively hands off with the companies it buys; just look at Genentech, its U.S. subsidiary, for proof. And that way of doing business has served it well, particularly when it comes to growing its digital partnerships.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,